IL36A and melanoma: Increased IL-36 cytokine expression levels, in particular IL-36α, have been correlated with improved prognosis in several cancers including ovarian cancer [63], melanoma [64, 65], hepatocellular carcinoma (HCC) [66, 67], and colon adenocarcinoma [68].